AI-based polysomnography (PSG) algorithm to be developed, validated, and integrated into EnsoData’s EnsoSleep AI Scoring and Study Management platform. Partnership offers potential to enable accurate, scalable NT1 identification earlier in the care journey using PSG and address the unmet need for more timely diagnosis. The post EnsoData Announces Collaboration with Takeda to Improve Narcolepsy Type 1 Diagnostic Journey Using AI Tools and Technology appeared first on EnsoData.
